Postmenopausal estrogen and cardiovascular disease.
When data from the significant studies are assembled and analyzed, what is known about the impact of supplemental estrogen on the risk of cardiovascular disease in women after the menopause? What are the best clinical guidelines today?
Stampfer
M J
MJ
Brigham and Women's Hospital, Boston, USA.
Grodstein
F
F
Bechtel
S
S
D002318:Cardiovascular Diseases / Q000453:epidemiology / Q000517:prevention & control; D016022:Case-Control Studies; D003430:Cross-Sectional Studies; D015914:Estrogen Replacement Therapy; D004967:Estrogens / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008875:Middle Aged; D017698:Postmenopause; D011372:Progestins / Q000627:therapeutic use; D011446:Prospective Studies; D012307:Risk Factors